Last edition
News about "innovative medicines "
Novartis India Appoints DC Dave and Co as Cost Auditors for FY 2025-26
Novartis India has appointed M/s. DC Dave and Co., a firm of practicing cost accountants, as the cost auditors of the company for the financial year 2025–26.
Innovative Medicines | 29/07/2025 | By Dineshwori
Novartis Reports Double-Digit Sales Growth In Q2, Raises Full-Year Guidance
Novartis has reported a robust financial performance for the second quarter of 2025, with net sales reaching USD 14.1 billion, up 12 percent year-on-year.
Innovative Medicines | 17/07/2025 | By Dineshwori | 365
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy